To Assess Awareness of Healthcare Professionals and Students Towards Pharmacovigilance,materiovigilance, Vaccinesafety Surveillance and National Poison Information Centre in Gangtok, Sikkim
Main Article Content
Abstract
Background: Surveillance plays a pivotal role in providing insight into a lacuna and help the system to address it. Pharmacovigilance, Materiovigilance, Vaccine safety surveillance and Toxicovigilance programmes were started with the aim to address the need for surveillance and intervention.
Aim: To assess questionnaire-based survey on awareness of healthcare professionals and students of Gangtok, Sikkim towards Pharmacovigilance programme of India, Materiovigilance programme of India, Vaccine Safety Surveillance and National Poisons Information Centre.
Objective:
1. To assess the level of awareness among different individuals from questionnaires.
2. To investigate the role of ADR for mitigating the country’s economic burden and improving quality of life.
3. To generate meaningful insight from the integration of data for improving spontaneous reporting among healthcare professionals.
Methodology: A cross sectional questionnaire-based awareness study was conducted among healthcare professionals and students. The survey was designed using the information from the literature to assess the awareness among the healthcare professionals and students indulged in patient care and various literature were reviewed to investigate the role of ADR for mitigating the country’s economic burden and improving quality of life.
Result: The survey was completed with 172 participants. Out of the 172 participants, 132 (76.7%) were aware of the term PvPI, 82 (47.7%) were aware of the term MvPI, 135(78.5%) were aware of the term Vaccine Safety Surveillance and only 67 (39.0%) were aware of the term NPIC.
References
Knight PR, Knight PR, Bacon DR. (2002).
An unexplained death: Hannah Greener and chloroform.
Anaesthesiology, 96:1250–1253.
https://doi.org/10.1097/00000542-200205000-00030
Kim JH, Scialli AR. (2011).
Thalidomide: The tragedy of birth defects and the effective treatment of disease.
Toxicological Sciences, 122(1):1–6.
https://doi.org/10.1093/toxsci/kfr088
World Health Organization. (2002).
The Importance of pharmacovigilance.
Retrieved from https://www.who.int/publications/i/item/10665-42493
Lazarou J, Pomeranz BH, Corey PN. (1998).
Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies.
JAMA, 279(15):1200–1205.
doi:10.1001/jama.279.15.1200
Kalaiselvan V, Thota P, Singh GN. (2016).
Pharmacovigilance Programme of India: Recent developments and future perspectives.
Indian Journal of Pharmacology, 48(6):624–628.
doi:10.4103/0253-7613.194855
Pharmacovigilance Programme in India (PvPI).
Retrieved from https://www.ipc.gov.in/PvPI/about.html
India Pharmacovigilance Programme. (2022).
MvPI E-Newsletter, Issue 4.
Retrieved from https://www.ipc.gov.in/images/MvPI_E-Newsletter_Issue-4_2022.pdf
Saifuddin PK, Tandon M, Kalaiselvan V, Suroy B, Pattanshetti V, Prakash A, Medhi B. (2022).
Materiovigilance Programme of India: Current status and way forward.
Indian Journal of Pharmacology, 54(3):221–225.
doi:10.4103/ijp.ijp_837_21
Meher BR, Padhy BM, Srinivasan A, Mohanty RR. (2022).
Awareness, attitude, and practice of materiovigilance among medical professionals at a tertiary care institute.
Perspectives in Clinical Research, 13(2):94–98.
doi:10.4103/picr.PICR_187_19
Joshi J, Das MK, Polpakara D, Aneja S, Agarwal M, Arora NK. (2018).
Vaccine safety and surveillance for adverse events following immunization (AEFI) in India.
Indian Journal of Pediatrics, 85:139–148.
doi:10.1007/s12098-017-2532-9
Operational Guidelines for AEFI Surveillance in India. (2015).
Ministry of Health and Family Welfare, New Delhi.
Ministry of Health and Family Welfare, Government of India. (2022).
Adverse Events Following Immunization (AEFI) reports.
https://main.mohfw.gov.in/Organisation/Departments-of-Health-and-Family-Welfare/immunization/aefi-reports
Das MK. (2023).
Adverse Events Following Immunization – The Known Unknowns and Black Box.
Indian Journal of Pediatrics.
doi:10.1007/s12098-023-04555-3
Goulding R. (1991).
Poisons information services: a look ahead.
Human & Experimental Toxicology, 10(6):401–404.
All India Institute of Medical Sciences (AIIMS). (2022).
About National Poisons Information Centre (NPIC).
https://www.aiims.edu/en/2020-01-23-09-22-24/about-npic.html
All India Institute of Medical Sciences (AIIMS). (2020).
Functioning of National Poisons Information Centre (NPIC).
https://www.aiims.edu/en/functioning-of-npic.html
Shah Peshin S, Gupta YK. (2018).
Poisoning due to household products: A ten years retrospective analysis.
Journal of Forensic and Legal Medicine, 58:205–211.
doi:10.1016/j.jflm.2018.07.005
Shah Peshin S, Srivastava A, Halder N, Gupta YK. (2014).
Pesticide poisoning trend analysis of 13 years.
Journal of Forensic and Legal Medicine, 22:57–61.
doi:10.1016/j.jflm.2013.12.013
Datta S, Sengupta S. (2015).
Evaluation of ADR reporting knowledge, attitude and practice.
Perspectives in Clinical Research, 6(4):200–206.
https://doi.org/10.4103/2229-3485.167096
Saifuddin PK et al. (2022).
Materiovigilance Programme of India: Current status and way forward.
Indian Journal of Pharmacology, 54(3):221–225.
Liu Z et al. (2021).
Active vaccine safety surveillance: global trends and challenges.
Health Data Science, 2021:9851067.
https://doi.org/10.34133/2021/9851067
Lall SB, Peshin SS. (1997).
Role and functions of Poisons Information Centre.
Indian Journal of Pediatrics, 64(4):443–449.
Sharma S, Dewan A, Singh G. (2017).
Toxicovigilance – an inevitable prerequisite.
Journal of Forensic and Legal Medicine, 45:32–35.
Vemparala C, Sharon T, Thalla S, Kantamneni P. (2020).
Role of pharmacist on economic burden of ADRs.
World Journal of Pharmaceutical and Life Sciences, 6(3):71–74.
Bushra R, Baloch SA, Jabeen A, Bano N, Aslam N. (2015).
Adverse drug reactions: factors and prevention.
Journal of Ayub Medical College Abbottabad, 27(3):702–706.
Fang H et al. (2017).
Interventions for improving spontaneous ADR reporting.
BMC Pharmacology and Toxicology, 18:49.
Vallano A et al. (2005).
Obstacles and solutions for ADR reporting in hospitals.
British Journal of Clinical Pharmacology, 60(6):653–658.
Kasliwal R. (2012).
Spontaneous reporting in pharmacovigilance: strengths and weaknesses.
Journal of Clinical and Preventive Cardiology, 1:20–23.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.